Carcinotech Ltd
United Kingdom
- Edinburgh, Midlothian
- 30/01/2024
- Unknown
- $5,330,157
Carcinotech is a MedTech company with expertise in manufacturing 3D printed micro-tumours using patient-derived biopsies, primary cells, immune cells and cancer stem cells. Carcinotech’s advanced models provide a platform for rapid, ethical, and accurate drug screening, pre-clinical and personalised medicine testing.
Working with global partners, leading pharma companies, surgeons, pathologists, clinicians, and industry-leaders, the goal is to accelerate drug screening and enable delivery of more effective cancer treatments to market. Access to Carcinotech’s robotic and automated manufacturing allows for accelerated production, with models offering high-throughput capabilities. We are a team of like-minded, highly-experienced and determined individuals, all sharing a vision for success. Learn more about our models, get in touch.
- Industry Biotechnology Research
- Website https://www.carcinotech.co.uk/
- LinkedIn https://www.linkedin.com/company/carcinotech-ltd/
Cosmico | $12,000,000 | (May 19, 2026)
Hacktron AI | $2,900,000 | (May 19, 2026)
Shyld AI | $13,400,000 | (May 19, 2026)
Onramp (1) | $12,500,000 | (May 19, 2026)
Sprouts.ai | $9,000,000 | (May 19, 2026)
Transient.AI | Undisclosed Amount | (May 19, 2026)
Furientis | $5,000,000 | (May 19, 2026)
Cimento AI | $3,000,000 | (May 19, 2026)
Multiverse | $70,000,000 | (May 19, 2026)
Blink - Employee Experience Platform | $17,000,000 | (May 19, 2026)
Elliptic | $120,000,000 | (May 19, 2026)
Arkeus | $18,000,000 | (May 19, 2026)
Greenpixie | $6,305,755 | (May 19, 2026)